Group Elephant business Valcann named Latin America’s ‘AWS Collaboration Partner of the Year’
ATLANTA, Dec. 9, 2024 /PRNewswire/ — AWS specialist Valcann, a member of the AWS Partner Network (APN), has been crowned ‘AWS Collaboration Partner of... Read more.
WSPN Partners with Fractal to Expand Stablecoin Access on Bitcoin
SINGAPORE, Dec. 8, 2024 /PRNewswire/ — WSPN (Worldwide Stablecoin Payment Network), a global digital payments company, today announced a strategic partnership... Read more.
2024 ASH Oral Presentation—-Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting
SHANGHAI, Dec. 8, 2024 /PRNewswire/ — December 8, 2024, Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results... Read more.
Global Total Semiconductor Equipment Sales Forecast to Reach a Record of $139 Billion in 2026, SEMI Reports
Front-end and Back-end Segments Projected to Support Consecutive Growth from 2024 through 2026 TOKYO, Dec. 9, 2024 /PRNewswire/ — Global sales of total semiconductor... Read more.
Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies toward ... Read more.
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimens demonstrate improved rates of minimal residual disease (MRD) negativity and progression-free survival in patients with newly diagnosed multiple myeloma
New analysis from Phase 3 CEPHEUS study demonstrates 85 percent of patients who achieved MRD negativity (10-6) with DARZALEX FASPRO® were progression free at 4.5... Read more.
Encouraging Efficacy and Safety: CStone Presents Latest Clinical Data on CS5001 for Advanced Lymphoma at the 66th ASH Annual Meeting
CS5001 is so far the first anti-ROR1 ADC known to show clinical anti-tumor activity in both solid tumors and lymphomas. The data presented at ASH highlighted the... Read more.
Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024
SAN FRANCISCO and SUZHOU, China, Dec. 8, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical... Read more.
AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients
-New insights show Black, Hispanic, and Asian patients have more negative emotional experiences and outlooks with their chronic lymphocytic leukemia (CLL) diagnosis... Read more.
Apple Sued for Knowingly Hosting Child Sexual Abuse Material on Its Products, Failing to Protect Survivors
Landmark lawsuit brought on behalf of thousands of survivors of child sexual abuse images and videos (CSAM) traded on Apple platforms CUPERTINO, Calif., Dec. 8,... Read more.